Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Accenture
Queensland Health
Daiichi Sankyo
Covington
Medtronic
Johnson and Johnson
Federal Trade Commission
Chubb

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,945,416

« Back to Dashboard

Summary for Patent: 5,945,416
Title: Method for treating pain
Abstract:The present invention provides a method for treating pain using a composition comprising olanzapine and Drug Useful in the Treatment of Pain.
Inventor(s): Shannon; Harlan E. (Carmel, IN), Womer; Daniel E. (Thornton, CO)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:08/823,461
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 5,945,416

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 5,945,416

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2543097 ➤ Try a Free Trial
Australia 725556 ➤ Try a Free Trial
Brazil 9708254 ➤ Try a Free Trial
Canada 2250187 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Federal Trade Commission
Deloitte
McKinsey
US Department of Justice
Argus Health
QuintilesIMS
AstraZeneca
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.